Illumina lowers Outlook due to China sales ban
China bans sales of Illumina DNA sequencers as Trump escalates global tariffs
Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting its DNA sequencers to China, which closed its doors to the company in response to the Trump administration expanding its tariffs on the country.
Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...
China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war ...
In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...
Illumina shareholders received a warning shot. In response to President Trump’s initial tariff measures, the Chinese ...
Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...
Illumina (ILMN) is reducing its forecast for this year’s financial performance and cutting $100M in spending because China barred sales of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback